Flagship Pioneering Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 59
Professionals
  • Investments
  • 331
  • Portfolio
  • 33
  • Exits
  • 154
Exits

Flagship Pioneering General Information

Description

Founded in 2000, Flagship Pioneering is a venture capital investment firm that prefers to invest in the health technologies and life science sectors. The firm is based in Cambridge, Massachusetts.

Contact Information

Formerly Known As
Flagship Ventures
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 55 Cambridge Parkway
  • Suite 800 East
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Flagship Pioneering Investments (331)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Vesalius Therapeutics 01-Mar-2022 Early Stage VC 0000 Drug Discovery Startup 000000 000000 00.0
00000000 000000000 18-Nov-2021 00000 00000 00000 Discovery Tools (Healthcare) Generating Revenue 00000000 000 00000000 00.0
0000 15-Nov-2021 0000 00000 Drug Discovery Generating Revenue 0000 000000
0000000 09-Nov-2021 00000 00000 0000 Drug Discovery Startup 000000 00000000 00.0
0000000 000000 02-Sep-2021 00000 00000 0000 Other Devices and Supplies Generating Revenue 000000 000000 00.0
0000000 28-Jul-2021 00000 00000 00000 Drug Discovery Startup 0000 00000000 00.0
0000 000000000000 28-Jul-2021 00000 00000 00000 Biotechnology Generating Revenue 0000 000000000 00.0
00000 00000000000 10-Jun-2021 00000 00000 0000 Drug Discovery Startup 000000000 000000 00.0
Inari 12-May-2021 Later Stage VC 00000 Other Agriculture Generating Revenue 000000 00000000 00.0
Repertoire Immune Medicines 13-Apr-2021 Later Stage VC 00000 Biotechnology Generating Revenue 0000000 0000 00
You’re viewing 10 of 331 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Flagship Pioneering Exits (154)

Company Name Exit Date Exit Type Exit Size
Novomer 11-Aug-2021 Merger/Acquisition 00000
00000 000000000000 30-Jul-2021 000 00000
000000 000000 0000 27-Jul-2021 000000000000000000 0000
00000 01-Jun-2021 000000000 00000000
0000000 0000000 01-Jun-2021 000000000 00000000
00000 00000000000 28-Apr-2021 000 00 00000000
0000000 10-Mar-2021 000000000000000000 000.00
000000 12-Feb-2021 000000 0000000000 000.00
Sana Biotechnology 04-Feb-2021 IPO 00000
Sigilon Therapeutics 04-Dec-2020 IPO 00000
You’re viewing 10 of 154 exits. Get the full list »

Flagship Pioneering Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Flagship Pioneering‘s full profile, request access.

Request a free trial

Flagship Pioneering Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Flagship Pioneering Team (133)

Name Title Deals Funds Boards Office
Noubar Afeyan Ph.D Co-Founder & Chief Executive Officer 00 0 00 Cambridge, MA
Chuck Carelli Chief Financial Officer Cambridge, MA
Jeffery Moore Chief Financial Officer, Flagship Labs Cambridge, MA
Robert Rosiello Executive Partner & Chief Operating Officer 0 Cambridge, MA
Douglas Cole MD Managing Partner 00 0 0 Cambridge, MA
You’re viewing 5 of 133 team members. Get the full list »

Flagship Pioneering Co-Investors (102)

Name With Exits Lead Partner Series Industry
The Invus Group 7 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
Alaska Permanent Fund 0 0 Series chart Industry bar
Longevity Vision Fund 0 0 Series chart Industry bar
T. Rowe Price 0 0 Series chart Industry bar
You’re viewing 5 of 102 co-investors. Get the full list »